Ultragenyx Pharmaceutical Inc. (RARE)
NASDAQ · Healthcare
Ultragenyx Pharmaceutical Inc. EPS 2016–2025
Ultragenyx Pharmaceutical Inc. annual/quarterly eps history and growth rate from 2020 to 2026. Earnings per share (EPS) is a company's net profit divided by the number of diluted shares outstanding. Higher EPS generally indicates greater profitability.
- Ultragenyx Pharmaceutical Inc. eps for the quarter ending March 31, 2026 was $1.84, a 17.20% increase year-over-year.
- Ultragenyx Pharmaceutical Inc. annual eps for 2025 was $5.83, a 7.31% decrease from 2024.
- Ultragenyx Pharmaceutical Inc. annual eps for 2024 was $6.29, a 23.76% decrease from 2023.
- Ultragenyx Pharmaceutical Inc. annual eps for 2023 was $8.25, a 18.48% decrease from 2022.
- Ultragenyx Pharmaceutical Inc. annual eps for 2022 was $10.12.
EPS
ANNUAL · USD
QUARTERLY · USD
YEAR-OVER-YEAR GROWTH · %
Ultragenyx Pharmaceutical Inc. EPS — FAQ
Ultragenyx Pharmaceutical Inc. (RARE) eps over the last 10 years — annual and quarterly figures with year-over-year growth and charts.
What is Ultragenyx Pharmaceutical Inc.'s eps?
Ultragenyx Pharmaceutical Inc. (RARE) reported eps of $-5.83 for fiscal 2025.
Where can I see RARE's eps history?
The chart and table above show Ultragenyx Pharmaceutical Inc.'s eps by year and by quarter, including the growth rate.